These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25483087)

  • 1. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
    Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
    Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Tcf-4 induces apoptosis and enhances chemosensitivity of colon cancer cells.
    Xie J; Xiang DB; Wang H; Zhao C; Chen J; Xiong F; Li TY; Wang XL
    PLoS One; 2012; 7(9):e45617. PubMed ID: 23029137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.
    Narasipura SD; Henderson LJ; Fu SW; Chen L; Kashanchi F; Al-Harthi L
    J Virol; 2012 Feb; 86(4):1911-21. PubMed ID: 22156527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid: a potential inducer of colon cancer stem cells.
    Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
    Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
    Valenta T; Lukas J; Korinek V
    Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
    Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
    Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
    Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
    Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
    Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
    Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms.
    Ibrahim EE; Babaei-Jadidi R; Saadeddin A; Spencer-Dene B; Hossaini S; Abuzinadah M; Li N; Fadhil W; Ilyas M; Bonnet D; Nateri AS
    Stem Cells; 2012 Oct; 30(10):2076-87. PubMed ID: 22851508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
    Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
    Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma.
    Chen L; Huang K; Han L; Shi Z; Zhang K; Pu P; Jiang C; Kang C
    Int J Oncol; 2011 Oct; 39(4):883-90. PubMed ID: 21720709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.
    Di Cecilia S; Zhang F; Sancho A; Li S; Aguiló F; Sun Y; Rengasamy M; Zhang W; Del Vecchio L; Salvatore F; Walsh MJ
    Cancer Res; 2016 Oct; 76(19):5615-5627. PubMed ID: 27520449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of C-terminal binding protein in human cancer.
    Straza MW; Paliwal S; Kovi RC; Rajeshkumar B; Trenh P; Parker D; Whalen GF; Lyle S; Schiffer CA; Grossman SR
    Cell Cycle; 2010 Sep; 9(18):3740-50. PubMed ID: 20930544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.